Table 3.

Specificity (%) of ELISA-rHsp83 and ELISA–L. major-like for other infectious disease samples

Samples	N	ELISA-rHsp83		ELISA–L. major-like
		Specificity (%)	CI (%)	Specificity (%)	CI (%)
Chagas disease	23	100.0*	85.18–100.0	8.70	1.07–28.04
Blastomycosis	7	100.0	59.04–100.0	85.71	42.13–99.64
Histoplasmosis	6	100.0	54.07–100.0	83.33	35.88–99.58
Aspergillosis	5	80.00	28.36–99.49	100.0	47.82–100.0
Cromomycosis	7	100.0	59.04–100.0	100.0	59.04–100.0
Toxoplasmosis	14	92.86	66.13–99.82	100.0	76.84–100.0
Cytomegalovirosis	4	100.0	39.76–100.0	100.0	39.76–100.0
Malaria	9	100.0	66.37–100.0	100.0	67.37–100.0
Tuberculosis	4	100.0	39.76–100.0	100.0	39.76–100.0
Total	79	97.47*	74.97–91.90	70.89	58.25–79.47

^*P < 0.001 compared with ELISA–L. major-like (McNemar's test).